Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,296 | -4,023 | -42,429 | -13,342 | -9,453 |
| Depreciation Amortization | 9 | 7 | 124 | 116 | 106 |
| Income taxes - deferred | -735 | -289 | -9,542 | N/A | N/A |
| Accounts receivable | -35 | -35 | -302 | -268 | -359 |
| Accounts payable and accrued liabilities | -1,986 | -1,449 | 411 | 478 | 926 |
| Other Working Capital | -2,490 | -2,026 | 181 | -172 | -137 |
| Other Operating Activity | 4,180 | 1,575 | 35,644 | 601 | 52 |
| Operating Cash Flow | $-8,353 | $-6,240 | $-15,913 | $-12,587 | $-8,865 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 18,185 | 8,170 | 13,171 |
| PPE Investments | 110 | N/A | -17 | -9 | -9 |
| Purchase Sale Intangibles | N/A | N/A | -5,015 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -5,015 | 0 | 0 |
| Investing Cash Flow | $110 | $N/A | $13,153 | $8,161 | $13,162 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,359 | N/A | 304 | 304 | 304 |
| Financing Cash Flow | $7,359 | $N/A | $304 | $304 | $304 |
| Exchange Rate Effect | N/A | -2 | -8 | 24 | -14 |
| Beginning Cash Position | 27,875 | 27,875 | 30,339 | 30,339 | 30,339 |
| End Cash Position | 26,991 | 21,633 | 27,875 | 26,241 | 34,926 |
| Net Cash Flow | $-884 | $-6,242 | $-2,464 | $-4,098 | $4,587 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,353 | -6,240 | -15,913 | -12,587 | -8,865 |
| Capital Expenditure | N/A | N/A | -17 | -9 | -9 |
| Free Cash Flow | -8,353 | -6,240 | -15,930 | -12,596 | -8,874 |